Skip to main content
Top
Published in: Diabetologia 9/2007

01-09-2007 | Article

Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes

Authors: L. Zheng, Y. Du, C. Miller, R. A. Gubitosi-Klug, T. S. Kern, S. Ball, B. A. Berkowitz

Published in: Diabetologia | Issue 9/2007

Login to get access

Abstract

Aims/hypothesis

Diabetes results in the upregulation of the production of several components of the inflammatory response in the retina, including inducible nitric oxide synthase (iNOS). The aim of this study was to investigate the role of iNOS in the pathogenesis of the early stages of diabetic retinopathy using iNOS-deficient mice (iNos /).

Materials and methods

iNos −/− mice and wild-type (WT; C57BL/6J) mice were made diabetic with streptozotocin or kept as non-diabetic controls. Mice were killed at different time points after the induction of diabetes for assessment of vascular histopathology, cell loss in the ganglion cell layer (GCL), retinal thickness, and biochemical and physiological abnormalities.

Results

The concentrations of nitric oxide, nitration of proteins, poly(ADP-ribose) (PAR)-modified proteins, endothelial nitric oxide synthase, prostaglandin E2, superoxide and leucostasis were significantly (p < 0.05) increased in retinas of WT mice diabetic for 2 months compared with non-diabetic WT mice. All of these abnormalities except PAR-modified proteins in retinas were inhibited (p < 0.05) in diabetic iNos −/− mice. The number of acellular capillaries and pericyte ghosts was significantly increased in retinas from WT mice diabetic for 9 months compared with non-diabetic WT controls, these increases being significantly inhibited in diabetic iNos −/− mice (p < 0.05 for all). Retinas from WT diabetic mice were significantly thinner than those from their non-diabetic controls, whereas diabetic iNos −/− mice were protected from this abnormality. We found no evidence of cell loss in the GCL of diabetic WT or iNos −/− mice. Deletion of iNos had no beneficial effect on diabetes-induced abnormalities on the electroretinogram.

Conclusions/interpretation

We demonstrate that the inflammatory enzyme iNOS plays an important role in the pathogenesis of vascular lesions characteristic of the early stages of diabetic retinopathy in mice.
Literature
1.
go back to reference Korhonen R, Lahti A, Kankaanranta H, Moilanen E (2005) Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 4:471–479PubMedCrossRef Korhonen R, Lahti A, Kankaanranta H, Moilanen E (2005) Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 4:471–479PubMedCrossRef
2.
go back to reference Ricciardolo FL, Nijkamp FP, Folkerts G (2006) Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Curr Drug Targets 7:721–735PubMedCrossRef Ricciardolo FL, Nijkamp FP, Folkerts G (2006) Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Curr Drug Targets 7:721–735PubMedCrossRef
3.
go back to reference Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC (2000) Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto–Kakizaki rats: correlation with blood–retinal barrier permeability. Nitric Oxide 4:590–596PubMedCrossRef Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC (2000) Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto–Kakizaki rats: correlation with blood–retinal barrier permeability. Nitric Oxide 4:590–596PubMedCrossRef
4.
go back to reference Du Y, Smith MA, Miller CM, Kern TS (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771–779PubMedCrossRef Du Y, Smith MA, Miller CM, Kern TS (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771–779PubMedCrossRef
5.
go back to reference Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K (2001) Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 132:551–556PubMedCrossRef Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K (2001) Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 132:551–556PubMedCrossRef
6.
go back to reference Ellis EA, Guberski DL, Hutson B, Grant MB (2002) Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 6:295–304PubMedCrossRef Ellis EA, Guberski DL, Hutson B, Grant MB (2002) Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 6:295–304PubMedCrossRef
7.
go back to reference Misko TP, Moore WM, Kasten TP et al (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119–125PubMedCrossRef Misko TP, Moore WM, Kasten TP et al (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119–125PubMedCrossRef
8.
go back to reference Kern TS, Engerman RL (2001) Pharmacologic inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50:1636–1642PubMedCrossRef Kern TS, Engerman RL (2001) Pharmacologic inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50:1636–1642PubMedCrossRef
9.
go back to reference Hammes H, Martin S, Federlin K, Geisen K, Brownlee M (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A 88:11555–11558PubMedCrossRef Hammes H, Martin S, Federlin K, Geisen K, Brownlee M (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A 88:11555–11558PubMedCrossRef
10.
go back to reference Kern TS, Tang J, Mizutani M et al (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972–3978PubMed Kern TS, Tang J, Mizutani M et al (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972–3978PubMed
11.
go back to reference Edelstein D, Brownlee M (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41:26–29PubMedCrossRef Edelstein D, Brownlee M (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41:26–29PubMedCrossRef
12.
go back to reference Zhao W, Tilton RG, Corbett JA et al (1996) Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol 64:123–133PubMedCrossRef Zhao W, Tilton RG, Corbett JA et al (1996) Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol 64:123–133PubMedCrossRef
13.
go back to reference Du Y, Sarthy V, Kern T (2004) Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol 287:R735–R741 Du Y, Sarthy V, Kern T (2004) Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol 287:R735–R741
14.
go back to reference Kowluru RA, Engerman RL, Kern TS (2000) Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr Eye Res 21:814–819PubMedCrossRef Kowluru RA, Engerman RL, Kern TS (2000) Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr Eye Res 21:814–819PubMedCrossRef
15.
go back to reference Du Y, Miller CM, Kern TS (2003) Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 35:1491–1499PubMedCrossRef Du Y, Miller CM, Kern TS (2003) Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 35:1491–1499PubMedCrossRef
16.
go back to reference Joussen AM, Poulaki V, Le ML et al (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450–1452PubMed Joussen AM, Poulaki V, Le ML et al (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450–1452PubMed
17.
go back to reference Zheng L, Szabo C, Kern TS (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53:2960–2967PubMedCrossRef Zheng L, Szabo C, Kern TS (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53:2960–2967PubMedCrossRef
18.
go back to reference Ball SL, Powers PA, Shin HS, Morgans CW, Peachey NS, Gregg RG (2002) Role of the beta(2) subunit of voltage-dependent calcium channels in the retinal outer plexiform layer. Invest Ophthalmol Vis Sci 43:1595–1603PubMed Ball SL, Powers PA, Shin HS, Morgans CW, Peachey NS, Gregg RG (2002) Role of the beta(2) subunit of voltage-dependent calcium channels in the retinal outer plexiform layer. Invest Ophthalmol Vis Sci 43:1595–1603PubMed
19.
go back to reference Hancock HA, Kraft TW (2004) Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 45:1002–1008PubMedCrossRef Hancock HA, Kraft TW (2004) Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 45:1002–1008PubMedCrossRef
20.
go back to reference Kowluru RA (2002) Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res 24:123–128PubMedCrossRef Kowluru RA (2002) Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr Eye Res 24:123–128PubMedCrossRef
21.
go back to reference Joussen AM, Poulaki V, Qin W et al (2002) Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 160:501–509PubMed Joussen AM, Poulaki V, Qin W et al (2002) Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 160:501–509PubMed
22.
go back to reference Joussen AM, Poulaki V, Mitsiades N et al (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16:438–440PubMed Joussen AM, Poulaki V, Mitsiades N et al (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16:438–440PubMed
23.
go back to reference Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375–429PubMedCrossRef Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375–429PubMedCrossRef
24.
go back to reference Xia Y, Zweier JL (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A 94:6954–6958PubMedCrossRef Xia Y, Zweier JL (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A 94:6954–6958PubMedCrossRef
25.
go back to reference Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158:147–152PubMed Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158:147–152PubMed
26.
go back to reference Berkowitz BA, Luan H, Gupta RR et al (2004) Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase. Diabetes 53:173–178PubMedCrossRef Berkowitz BA, Luan H, Gupta RR et al (2004) Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase. Diabetes 53:173–178PubMedCrossRef
27.
go back to reference Berkowitz BA, Roberts R, Luan H et al (2005) Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 46:2954–2960PubMedCrossRef Berkowitz BA, Roberts R, Luan H et al (2005) Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 46:2954–2960PubMedCrossRef
28.
go back to reference Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783–791PubMedCrossRef Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783–791PubMedCrossRef
29.
go back to reference VanGuilder HD, Ellis RW, Freeman WM, Barber AJ (2006) Streptozotocin-diabetes decreases synaptic protein expression in rat retina. Invest Ophthalmol Vis Sci 47:1733 (ARVO E-Abstract) VanGuilder HD, Ellis RW, Freeman WM, Barber AJ (2006) Streptozotocin-diabetes decreases synaptic protein expression in rat retina. Invest Ophthalmol Vis Sci 47:1733 (ARVO E-Abstract)
30.
go back to reference Hammes HP, Federoff HJ, Brownlee M (1995) Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1:527–534PubMed Hammes HP, Federoff HJ, Brownlee M (1995) Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1:527–534PubMed
31.
go back to reference Lieth E, Gardner TW, Barber AJ, Antonetti DA, Penn State Retina Research Group (2000) Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 28:3–8PubMedCrossRef Lieth E, Gardner TW, Barber AJ, Antonetti DA, Penn State Retina Research Group (2000) Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 28:3–8PubMedCrossRef
32.
go back to reference Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M (2003) A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506–511PubMedCrossRef Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M (2003) A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506–511PubMedCrossRef
33.
go back to reference Feit-Leichman RA, Kinouchi R, Takeda M et al (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46:4281–4287PubMedCrossRef Feit-Leichman RA, Kinouchi R, Takeda M et al (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46:4281–4287PubMedCrossRef
34.
go back to reference Agardh E, Bruun A, Agardh CD (2001) Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes. Curr Eye Res 23:276–284PubMedCrossRef Agardh E, Bruun A, Agardh CD (2001) Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes. Curr Eye Res 23:276–284PubMedCrossRef
35.
go back to reference Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330–3336PubMedCrossRef Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330–3336PubMedCrossRef
36.
go back to reference Barber AJ, Antonetti DA, Kern TS et al (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210–2218PubMedCrossRef Barber AJ, Antonetti DA, Kern TS et al (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210–2218PubMedCrossRef
37.
go back to reference Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424–C1437PubMed Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424–C1437PubMed
38.
go back to reference Burney S, Caulfield JL, Niles JC, Wishnok JS, Tannenbaum SR (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 424:37–49PubMed Burney S, Caulfield JL, Niles JC, Wishnok JS, Tannenbaum SR (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 424:37–49PubMed
39.
go back to reference Szabo C, Ohshima H (1997) DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1:373–385PubMedCrossRef Szabo C, Ohshima H (1997) DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1:373–385PubMedCrossRef
40.
go back to reference Ellis EA, Sengupta N, Caballero S, Guthrie SM, Mames RN, Grant MB (2005) Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia. Antioxid Redox Signal 7:1413–1422PubMedCrossRef Ellis EA, Sengupta N, Caballero S, Guthrie SM, Mames RN, Grant MB (2005) Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia. Antioxid Redox Signal 7:1413–1422PubMedCrossRef
41.
go back to reference Sugawara T, Lewen A, Gasche Y, Yu F, Chan PH (2002) Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB J 16:1997–1999PubMed Sugawara T, Lewen A, Gasche Y, Yu F, Chan PH (2002) Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB J 16:1997–1999PubMed
42.
go back to reference Sugawara T, Noshita N, Lewen A et al (2002) Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci 22:209–217PubMed Sugawara T, Noshita N, Lewen A et al (2002) Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci 22:209–217PubMed
43.
go back to reference Abu El-Asrar AM, Meersschaert A, Dralands L, Missotten L, Geboes K (2004) Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye 18:306–313PubMedCrossRef Abu El-Asrar AM, Meersschaert A, Dralands L, Missotten L, Geboes K (2004) Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye 18:306–313PubMedCrossRef
44.
go back to reference Kim J, Oh YS, Shinn SH (2005) Troglitazone reverses the inhibition of nitric oxide production by high glucose in cultured bovine retinal pericytes. Exp Eye Res 81:65–70PubMedCrossRef Kim J, Oh YS, Shinn SH (2005) Troglitazone reverses the inhibition of nitric oxide production by high glucose in cultured bovine retinal pericytes. Exp Eye Res 81:65–70PubMedCrossRef
45.
go back to reference Park JW, Park SJ, Park SH et al (2006) Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina. Neurobiol Dis 21:43–49PubMedCrossRef Park JW, Park SJ, Park SH et al (2006) Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina. Neurobiol Dis 21:43–49PubMedCrossRef
46.
go back to reference Takeda M, Mori F, Yoshida A et al (2001) Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats. Diabetologia 44:1043–1050PubMedCrossRef Takeda M, Mori F, Yoshida A et al (2001) Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats. Diabetologia 44:1043–1050PubMedCrossRef
47.
go back to reference Huang PL, Huang Z, Mashimo H et al (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242PubMedCrossRef Huang PL, Huang Z, Mashimo H et al (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242PubMedCrossRef
48.
go back to reference Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241–2248PubMedCrossRef Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M (2002) Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241–2248PubMedCrossRef
49.
go back to reference Kowluru RA, Koppolu P, Chakrabarti S, Chen S (2003) Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res 37:1169–1180PubMedCrossRef Kowluru RA, Koppolu P, Chakrabarti S, Chen S (2003) Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res 37:1169–1180PubMedCrossRef
50.
go back to reference Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP (2004) Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165:457–469PubMed Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP (2004) Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165:457–469PubMed
51.
go back to reference Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS (2007) Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 56:337–345PubMedCrossRef Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS (2007) Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 56:337–345PubMedCrossRef
52.
go back to reference Kern TS, Miller CM, Du Y et al (2007) Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56:373–379PubMedCrossRef Kern TS, Miller CM, Du Y et al (2007) Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56:373–379PubMedCrossRef
Metadata
Title
Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes
Authors
L. Zheng
Y. Du
C. Miller
R. A. Gubitosi-Klug
T. S. Kern
S. Ball
B. A. Berkowitz
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0734-9

Other articles of this Issue 9/2007

Diabetologia 9/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.